Kenya’s government is actively pursuing a dedicated financing fund to bolster the domestic production of pharmaceuticals, vaccines, and other crucial health products. This initiative follows a meeting between Principal Secretary for Medical Services, Dr. Ouma Oluga, and CEOs from Consolidated Bank and the Kenya BioVax Institute. The partnership aims to reduce reliance on imports and strengthen the country’s healthcare supply chain. Discussions centered on establishing a financial mechanism to support local manufacturers and promote self-sufficiency in essential medical supplies. Authorities hope this will improve access to affordable healthcare for citizens and enhance national health security. The fund represents a strategic move toward a more resilient and independent healthcare system for Kenya. Further details regarding the fund’s operationalization are expected to be announced soon.